{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T08:08:27Z","timestamp":1772784507507,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Crohn's and Colitis"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.crohns.2011.11.010","type":"journal-article","created":{"date-parts":[[2011,12,19]],"date-time":"2011-12-19T15:32:25Z","timestamp":1324308745000},"page":"597-602","source":"Crossref","is-referenced-by-count":35,"title":["A functional polymorphism in UGT1A1 related to hyperbilirubinemia is associated with a decreased risk for Crohn's disease"],"prefix":"10.1093","volume":"6","author":[{"given":"Hilbert S.","family":"de Vries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rene H.M.","family":"te Morsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin","family":"Jenniskens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilbert H.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk J.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1016\/j.crohns.2011.11.010_bb0005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/nature06005","article-title":"Unravelling the pathogenesis of inflammatory bowel disease","volume":"448","author":"Xavier","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.crohns.2011.11.010_bb0010","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1007\/s10620-006-9622-2","article-title":"Oxidative stress and pathogenesis of inflammatory bowel disease: an epiphenomenon or the cause?","volume":"52","author":"Rezaie","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.crohns.2011.11.010_bb0015","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1046\/j.1365-2036.2002.01378.x","article-title":"Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease \u2014 radicals or ridiculous?","volume":"16","author":"Kruidenier","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2011.11.010_bb0020","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0016-5085(92)91112-H","article-title":"Chemiluminescence assay of mucosal reactive oxygen metabolites in inflammatory bowel disease","volume":"103","author":"Simmonds","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2011.11.010_bb0025","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/ibd.21552","article-title":"Oxidative state and IL-6 production in intestinal myofibroblasts of Crohn's disease patients","volume":"17","author":"Catarzi","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.11.010_bb0030","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/ibd.21027","article-title":"Mitochondrial dysfunction, persistent oxidative damage, and catalase inhibition in immune cells of na\u00efve and treated Crohn's disease","volume":"16","author":"Beltr\u00e1n","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.11.010_bb0035","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.3748\/wjg.14.1972","article-title":"Current view of the immunopathogenesis in inflammatory bowel disease and its implications for therapy","volume":"14","author":"Torres","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0040","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1042\/BST0391102","article-title":"Role of oxidative stress and antioxidant enzymes in Crohn's disease","volume":"39","author":"Iborra","year":"2011","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.crohns.2011.11.010_bb0045","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1126\/science.3029864","article-title":"Bilirubin is an antioxidant of possible physiological importance","volume":"235","author":"Stocker","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.crohns.2011.11.010_bb0050","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1073\/pnas.84.16.5918","article-title":"Antioxidant activity of albumin-bound bilirubin","volume":"84","author":"Stocker","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.crohns.2011.11.010_bb0055","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/clinchem\/46.11.1723","article-title":"Association of serum bilirubin concentration with risk of coronary artery disease","volume":"46","author":"Mayer","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.crohns.2011.11.010_bb0060","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.2011.124","article-title":"Serum bilirubin and risk of respiratory disease and death","volume":"305","author":"Horsfall","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.crohns.2011.11.010_bb0065","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/hep.1840400412","article-title":"Serum bilirubin levels in the U.S. population: gender effect and inverse correlation with colorectal cancer","volume":"40","author":"Zucker","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.crohns.2011.11.010_bb0070","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1023\/A:1013794407325","article-title":"Serum bilirubin and 10-year mortality risk in a Belgian population","volume":"12","author":"Temme","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.crohns.2011.11.010_bb0075","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJM199511023331802","article-title":"The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome","volume":"333","author":"Bosma","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.crohns.2011.11.010_bb0080","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(96)91273-8","article-title":"Genetic variation in bilirubin UPD glucuronosyltransferase gene promoter and Gilbert's syndrome","volume":"347","author":"Monaghan","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.crohns.2011.11.010_bb0085","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0168-8278(02)00359-8","article-title":"Inherited disorders of bilirubin metabolism","volume":"38","author":"Bosma","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0090","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2215\/CJN.06130710","article-title":"Serum bilirubin links UGT1A1*28 polymorphism and predicts long-term cardiovascular events and mortality in chronic hemodialysis patients","volume":"6","author":"Chen","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0095","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0168-8278(00)80268-8","article-title":"Association of human liver bilirubin UDP-glucuronosyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene","volume":"33","author":"Raijmakers","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0100","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0168-8278(02)00306-9","article-title":"Combined polymorphisms in UDP glucuronosyltransferases 1A1 and 1A6: implications for patients with Gilbert's syndrome","volume":"38","author":"Peters","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0105","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1093\/hmg\/ddp202","article-title":"Genome-wide association meta-analysis for total serum bilirubin levels","volume":"18","author":"Johnson","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.crohns.2011.11.010_bb0110","doi-asserted-by":"crossref","first-page":"606","DOI":"10.4065\/mcp.2011.0178","article-title":"Mayo Genome Consortia: a genotype\u2013phenotype resource for genome-wide association studies with an application to the analysis of circulating bilirubin levels","volume":"86","author":"Bielinski","year":"2011","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.crohns.2011.11.010_bb0115","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/00042737-200605000-00018","article-title":"Nodular regenerative hyperplasia: a reversible entity associated with azathioprine therapy","volume":"18","author":"Seiderer","year":"2006","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/path.2766","article-title":"Pharmacogenetic tests in cancer chemotherapy: what physicians should know for clinical application","volume":"223","author":"Lee","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0125","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1053\/j.gastro.2011.02.045","article-title":"Conventional medical management of inflammatory bowel disease","volume":"140","author":"Burger","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.crohns.2011.11.010_bb0130","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","article-title":"Inflammatory bowel disease","volume":"347","author":"Podolsky","year":"2002","journal-title":"New Engl J Med"},{"key":"10.1016\/j.crohns.2011.11.010_bb0135","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0140","doi-asserted-by":"crossref","first-page":"e15011","DOI":"10.1371\/journal.pone.0015011","article-title":"The functional 765G\u2192C polymorphism of the Cox-2 gene may reduce the risk of developing Crohn's disease","volume":"5","author":"de Vries","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.crohns.2011.11.010_bb0145","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1002\/ijc.25296","article-title":"Genetic polymorphism in the conjugating enzyme UGT1A1 and the risk of head and neck cancer","volume":"127","author":"Lacko","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.crohns.2011.11.010_bb0235","doi-asserted-by":"crossref","DOI":"10.2202\/1544-6115.1542","article-title":"The generalized odds ratio as a measure of genetic risk effect in the analysis and meta-analysis of association studies","volume":"9","author":"Zintzaras","year":"2010","journal-title":"Stat Appl Genet Mol Biol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.5414\/CPP40233","article-title":"Predicting the risk of sporadic elevated bilirubin levels and diagnosing Gilbert's syndrome by genotyping UGT1A1*28 promoter polymorphism","volume":"40","author":"Rauchschwalbe","year":"2002","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.crohns.2011.11.010_bb0160","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1023\/B:DDAS.0000042242.22898.d9","article-title":"Decreased total and corrected antioxidant capacity in patients with inflammatory bowel disease","volume":"49","author":"Koutroubakis","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"Suppl. 1","key":"10.1016\/j.crohns.2011.11.010_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1365-2036.2004.01992.x","article-title":"Heme oxygenase-1: a new therapeutic target for inflammatory bowel disease","volume":"20","author":"Naito","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.crohns.2011.11.010_bb0170","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.4049\/jimmunol.1002433","article-title":"An anti-inflammatory role for carbon monoxide and heme oxygenase-1 in chronic th2-mediated murine colitis","volume":"186","author":"Sheikh","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0175","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1084\/jem.20051047","article-title":"Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway","volume":"202","author":"Hegazi","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.crohns.2011.11.010_bb0180","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1177\/0961203311411350","article-title":"Oxidative stress is associated with liver damage, inflammatory status, and corticosteroid therapy in patients with systemic lupus erythematosus","volume":"20","author":"Lozovoy","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.crohns.2011.11.010_bb0185","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1136\/ard.2010.132720","article-title":"Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice","volume":"70","author":"Wruck","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.crohns.2011.11.010_bb0190","first-page":"256","article-title":"Bilirubin as a protective factor for rheumatoid arthritis: an NHANES study of 2003\u20132006 data","volume":"2","author":"Fischman","year":"2010","journal-title":"J Clin Med Res"},{"key":"10.1016\/j.crohns.2011.11.010_bb0195","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/03009741003742748","article-title":"Association of systemic lupus erythematosus with low serum bilirubin levels","volume":"39","author":"V\u00edtek","year":"2010","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0200","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrd3228","article-title":"The therapeutic potential of carbon monoxide","volume":"9","author":"Motterlini","year":"2010","journal-title":"Nature Rev Drug Disc"},{"key":"10.1016\/j.crohns.2011.11.010_bb0205","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.MIB.0000164017.06538.8a","article-title":"Heme oxygenase-1-generated biliverdin ameliorates experimental murine colitis","volume":"11","author":"Berberat","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.crohns.2011.11.010_bb0210","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejphar.2006.12.022","article-title":"Modulation by heme and zinc protoporphyrin of colonic heme oxygenase-1 and experimental inflammatory bowel disease in the rat","volume":"561","author":"Varga","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0215","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1136\/jcp.2009.069252","article-title":"Thiopurine S-methyltransferase (TPMT) assessment prior to starting thiopurine drug treatment; a pharmacogenomic test whose time has come","volume":"63","author":"Ford","year":"2010","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0220","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.3748\/wjg.v16.i25.3187","article-title":"Thiopurine S-methyltransferase polymorphisms and thiopurine toxicity in treatment of inflammatory bowel disease","volume":"16","author":"Dong","year":"2010","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.crohns.2011.11.010_bb0225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/FPC.0b013e3283449200","article-title":"Evidence for a functional genetic polymorphism of the Rho-GTPase Rac1. Implication in azathioprine response?","volume":"21","author":"Bourgine","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.crohns.2011.11.010_bb0230","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.clinbiochem.2009.08.011","article-title":"Haplotypes in the UGT1A1 gene and their role as genetic determinants of bilirubin concentration in healthy German volunteers","volume":"42","author":"Borucki","year":"2009","journal-title":"Clin Biochem"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611003242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S1873994611003242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/6\/5\/597\/7094283\/6-5-597.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T00:12:25Z","timestamp":1593389545000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article-lookup\/doi\/10.1016\/j.crohns.2011.11.010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1873994611003242"],"URL":"https:\/\/doi.org\/10.1016\/j.crohns.2011.11.010","relation":{},"ISSN":["1873-9946"],"issn-type":[{"value":"1873-9946","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}